FDA
-
-
-
-
-
-
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
-
-
-
-
-
-
-
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
-
-
-
-
-
-
-
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
-
-
-
-
-
-
-
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
-
-
-
-
-
-
-
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy
-
-
-
-
-
-
-
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
-
322,199 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

